What limits the dissolution of the weakly acidic polymer HP-50 at pH 6.8, and does pre-ionizing it as a polymer salt speed up the polymer and the release of a lipophilic drug from its ASD?
Buffers whose pKa lies near pH 6.8 dissolve HP-50 fastest, which the authors read as proton removal from the surface being the limit. ·· Pre-ionized salts dissolved about 3-fold faster, the sodium salt kept its rate when buffer capacity fell from 29 to 3 mM·ΔpH⁻¹, and salt ASDs released miconazole (20% DL) about 12 to 14 times faster than the HP-50 ASD. ··
For HP-50 dissolving as a compact at pH 6.8 and 37 °C, the authors conclude that polymer solubilization and hydration through ionization, tied to the transport of protons across the boundary layer, is "likely" the rate-limiting step (the abstract states it as identified). · Pre-ionization by salt formation removes the protons generated at the surface, so nine salts dissolved about 3-fold faster than HP-50 with little effect of the counterion, and the sodium salt kept its rate in low-capacity buffer while HP-50 slowed 6-fold; the authors take these comparisons to "confirm" the role of proton generation and removal. ··· Higher hydration of the salts is named "likely a key contributor", although the salt that took up the most water did not dissolve fastest. · With miconazole at 20% DL, ASDs on HP-50-Na or the triethylamine salt released about 84–90% of the drug in an hour, close to the polymer by the authors' reading, against about 9% from the HP-50 ASD. ··· The authors present polymer salts as a "potential" strategy for higher drug loadings and for release that is robust to intestinal buffer capacity; surface pH, gel-layer hydration, loadings above 20% and biorelevant or in vivo conditions were not measured. ···
01Why this study
Low intestinal buffer capacity is thought to lower the pH at the polymer surface and slow dissolution.
Ozturk 1988, ref 4; Harianawala 2002, ref 5
In an ASD the polymer itself must dissolve to free the drug, and the drug can change how fast it dissolves.
Percolation, surface and proton-carrier models have all been proposed.
Yeh 1992, ref 13; Tsiartas 1997, ref 12; Nguyen 2005, ref 11
More detail
The paper cites by author and year; "ref N" below is the position of the entry in the printed, unnumbered reference list (40 entries).
What was already known.
- Enteric coatings dissolve fast in vitro but lag in vivo. Scintigraphy studies found a lag before enteric-coated tablets disintegrate in the small intestine, while in 50 mM pH 6.8 phosphate buffer coatings disintegrate quickly. The gap "is thought to be due, at least in part" to the low buffer capacity of intestinal fluid, which lowers the pH at the polymer–water surface; a lower pH near a dissolving enteric film was measured and agrees with models. (Catteau 1994, ref 1; Lehmann 1997, ref 2; Wilding 1992, ref 3; Ozturk 1988, ref 4; Harianawala 2002, ref 5)
- Enteric polymers such as HPMCAS and HPMCP are now ASD carriers. Some drug can be released at gastric pH, the rest once the polymer dissolves in intestinal fluid, so complete release needs the intestinal pH to pass a threshold; how buffer capacity affects such ASDs had not been widely studied. (Bhujbal 2021, ref 6; Mudie 2021, ref 7; Elkhabaz 2019, ref 8)
- In an ASD, drug and polymer affect each other's dissolution. The drug is mixed at the molecular level, and the polymer must dissolve, not merely rupture, for the drug to leave; different drugs slow enteric polymers to different extents. (Hiew 2022, ref 9; Saboo 2020, ref 14; Yang 2021, ref 15) ·
- Polymer dissolution has several steps. Water ingress, chain disentanglement and diffusion across the aqueous boundary layer; enteric polymers must also ionize, which hydrates the chains and lets them disentangle by reptation. (Hunek 2002, ref 10; Nguyen 2005, ref 11)
- Three models disagree on the slow step. Reiser's percolation model makes solvent hopping between ionized sites in a gel layer limiting and needs a critical number of ionized sites; Willson's model has chains leaving only the outer surface, at a rate set by their ionization; both fit low-molecular-weight polymers. Nguyen and Fogler's model for an entangled enteric polymer adds buffer concentration and pKa relative to surface and bulk pH, hydrodynamics and disentanglement. (Yeh 1992, ref 13; Tsiartas 1997, ref 12; Nguyen 2005, ref 11)
- The model drug. Miconazole is a lipophilic, weakly basic BCS class II drug with pKa 6.5 and an amorphous solubility of about 5 µg/mL. (Yang 2021, ref 15)
What the paper set out to do. Understand the factors that set the dissolution rate of an enteric polymer used in ASDs: first by dissolving HPMCP (HP-50) in media that differ in buffer cation size, buffer pKa and concentration; then by making polymer salts to test pre-ionization and the counterion; finally by comparing miconazole release from ASDs made with the protonated polymer and with polymer salts.
02How they approached it
One enteric polymer, HP-50, dissolved as a 0.5 cm² rotating compact at pH 6.8 and 37 °C. First the medium was varied to find what limits it, then the polymer was pre-ionized as salts, then the best salts were used in a 20% miconazole ASD. ·
What was done
HP-50 compacts in pH 6.8 buffers of different cation, species and concentration→rotating-disk polymer release.···
HP-50 neutralized with sodium or eight amine and ammonium bases→sodium content, FTIR, TGA, Tg, water uptake at 100% RH.·
Salt compacts and partial BIS-TRIS salts→normalized dissolution rate.··
20% DL miconazole ASDs on HP-50, HP-50-Na and PTEA→drug (HPLC) and polymer (colorimetric) release.···
Salt versus HP-50 at high and low buffer capacity; drug release rate across the three carriers.·
Surface pH shift and critical ionization of HP-50 used to explain the rates.·
More detail
What was done
- Polymer salts. For each amine, 1.61 mmol (1.0 equivalent to the phthalic acid in 1.0 g HP-50) was added to HP-50 dissolved in methanol/dichloromethane (10:90), stirred 30–60 min and dried by rotary evaporation at 40 °C. The sodium salt was made with a sodium base and the tetrabutylammonium salt by salt metathesis (details in the SI, not supplied). Partial BIS-TRIS salts were made at 20, 50, 80, 90 and 95 mol%. ···
- Characterization. Sodium in HP-50-Na by ICP-OES after drying; ammonium content by 1H NMR; carboxylate formation by transmission FTIR of spin-coated films; thermal stability by TGA; Tg by modulated DSC (onset, scanned to 140 °C) and by DMA (tan δ peak, powder in compression).
- Water uptake. 200 mg of dried powder in an open vial at 100% RH and 37 °C, weighed up to 96 h.
- ASDs. Miconazole and polymer (20% DL) from dichloromethane/methanol (50:50) by rotary evaporation at 50 °C, dried 48 h, cryo-milled; the triethylamine-salt ASD can also be made in one pot.
- Dissolution. 100 mg of polymer or ASD powder compressed at 1500 psi into an 8 mm die (0.5 cm²) and rotated at 100 rpm in 100 mL buffer at 37 °C; default medium 50 mM sodium phosphate pH 6.8. Samples at 10–120 min were replaced with fresh buffer; miconazole by HPLC after dilution with methanol, polymer by the phenol–sulfuric acid assay. Rates are reported per unit area (mg·min⁻¹·cm⁻²). ···
- Media. Five phosphate buffers with different cations (sizes from 182 to 415 pm), three hydrochloric acid–amine buffers at 50 mM, and phosphate at 50 and 5 mM, whose buffer capacities were measured as 29 and 3 mM·ΔpH⁻¹. ···
Terms used on this page
- Buffer capacity: how much acid or base a medium can absorb per unit change in pH; here 29 mM·ΔpH⁻¹ for 50 mM and 3 for 5 mM phosphate.
- Surface pH: the pH right at the dissolving surface; for an acid it is lower than the bulk pH because ionization releases protons there.
- Proton carrier: a buffer species that picks up a proton at the surface, diffuses away and releases it in the bulk.
- Pre-ionization: neutralizing the polymer's acid groups with a base before use, so the solid is already a salt.
- Normalized (intrinsic) dissolution rate: mass dissolved per minute per square centimetre of a compact of fixed area.
- Congruent release: drug and polymer leave the solid at the same fractional rate.
03Main findings
The buffer species, not the cation size, sets how fast HP-50 dissolves
With five cations in phosphate buffer, ≈23–36% of HP-50 dissolved in 60 min. With different buffer species it ranged from ≈45% (BIS-TRIS) and ≈28% (phosphate) to ≈7% (Tris) and ≈2% (TEA), the order of increasing buffer pKa. ···
More detail
In 50 mM phosphate buffer at pH 6.8 with K, NH4, Cs, Na or tetrabutylammonium as cation, HP-50 release was linear in time and reached ≈35.0, ≈35.7, ≈33.5, ≈28.4 and ≈22.6% at 60 min. The cations span 182 to 415 pm; the authors single out only tetrabutylammonium as slightly slower and see little effect of cation size ("It is apparent"), although sodium (≈28.4%) also lies below K, NH4 and Cs. ··· Changing the buffer species at the same pH had a much larger effect: at 60 min ≈44.8% in BIS-TRIS, ≈28.4% in sodium phosphate, ≈6.6% in Tris and ≈1.8% in TEA buffer. The pKa values are 6.5, 7.2, 8.1 and 10.2, and the authors write that rate "appear[s] to trend" with buffer pKa and buffer capacity at pH 6.8: slow buffers have high pKa and low capacity, fast buffers a pKa near the dissolution pH. ····· Further buffers are in the SI, which was not supplied.
Salt formation ionizes HP-50 and multiplies its water uptake
HP-50-Na held 3.38–3.52 wt% sodium (91–95% of the acid groups) and showed a new carboxylate band. At 100% RH it took up ≈42% water in 96 h, the amine salts ≈25–30% and HP-50 ≈10%. ····
More detail
Elemental analysis gave 3.38–3.52 wt% sodium in HP-50-Na, which the authors convert to a 91–95% molar sodium content, "indicating nearly complete ionization"; the ammonium content of the amine salts was around 100% by 1H NMR, and NMR verified salt formation. ··· In the FTIR carbonyl region HP-50 shows one band near 1728 cm⁻¹, while HP-50-Na also shows a strong broad band around 1570–1610 cm⁻¹, read by the authors as carboxylate (1600 cm⁻¹). · Stored at 100% RH and 37 °C, the polymers took up water in the order HP-50-Na (≈13.0 → ≈42.4% from 5 to 96 h) > PBTM (≈30.1% at 96 h) > PTBA (≈25.5%) ≈ PDIP (≈24.6%) > HP-50 (≈9.7%, flat after 24 h). The authors note the differences between amine salts were "smaller than might be anticipated" from the cation structures. ·
Pre-ionized salts dissolve about three times faster than HP-50, whatever the counterion
Nine salts dissolved at ≈2.35–3.09 mg·min⁻¹·cm⁻² against ≈0.92 for HP-50; HP-50-Na (≈2.80) was about 3-fold faster and almost fully dissolved by 80 min. ···
More detail
In 50 mM phosphate buffer HP-50-Na dissolved ≈99% by 80 min against ≈39% for HP-50 (Fig. 5), which the authors call "~ 3-fold faster" (abstract and results) and "more than twice as fast" (discussion). · All eight amine or ammonium salts dissolved at rates similar to the sodium salt: PTBA ≈3.09, PBTM ≈2.93, PAMP ≈2.87, PMP ≈2.86, PTHAM ≈2.85, HP-50-Na ≈2.80, PTEA ≈2.53, PDIP ≈2.39 and PBTP ≈2.35 mg·min⁻¹·cm⁻², with overlapping error bars. The authors see "no notable difference" among cations, regardless of the molecular weight or lipophilicity of the amine; the lowest three are about 18–24% below the highest and no statistical test is reported. · The counterion pKa did not track the salt's rate, unlike the strong buffer effect on HP-50 (an SI comparison of the triethylamine salt with HP-50 in TEA buffer, not supplied).
The sodium salt keeps its rate when buffer capacity drops; HP-50 slows 6-fold
From 50 mM (29 mM·ΔpH⁻¹) to 5 mM phosphate (3 mM·ΔpH⁻¹), HP-50 fell from ≈0.92 to ≈0.14 mg·min⁻¹·cm⁻², while HP-50-Na went from ≈2.80 to ≈2.45. ·
More detail
The protonated polymer showed a "6-fold reduction" in rate (≈0.92 to ≈0.14 mg·min⁻¹·cm⁻²) when the phosphate concentration fell from 50 to 5 mM, which lowered the measured buffer capacity from 29 to 3 mM·ΔpH⁻¹. ··· The sodium salt dissolved at ≈2.80 and ≈2.45 mg·min⁻¹·cm⁻², with overlapping SD bars; the authors describe the rate as "the same" and "not impacted". ·· The salt also dissolved in plain water (an NMR spectrum was obtained), whereas HP-50 gave no NMR signal after addition to water. The authors note that intestinal buffer capacity varies between and within people and is much lower than that of 50 mM phosphate.
The more of the polymer is neutralized, the faster it dissolves, with the largest step between 80 and 100%
Partial BIS-TRIS salts dissolved at ≈1.22, ≈1.52 and ≈1.68 mg·min⁻¹·cm⁻² at 20, 50 and 80 mol% base and ≈2.93 at 100%, against ≈0.92 for HP-50. ·
More detail
Rate rose steadily with the amount of BIS-TRIS: ≈0.92 (HP-50, 0%), ≈1.22 (20%), ≈1.52 (50%), ≈1.68 (80%), ≈2.10 (90%), ≈2.23 (95%) and ≈2.93 mg·min⁻¹·cm⁻² (100%). The step from 80 to 100% gives the "almost 2-fold" decrease the authors stress; below 80% the decline is "more modest". · The x-axis is the mol% of base added; the ionization of the partial salts was not measured. The authors link the steep part to a critical ionization of about 83% estimated for HP-50 in earlier work ("may explain"). ·
Polymer-salt ASDs release miconazole about 12 to 14 times faster, nearly together with the polymer
At 20% DL, the HP-50 ASD released ≈9% of the drug in 60 min, with the polymer ahead of the drug; the HP-50-Na and PTEA ASDs released ≈90% and ≈84%. Normalized drug release rates were ≈0.22, ≈3.15 and ≈2.70 mg·min⁻¹·cm⁻². ···
See also Fig. 11
More detail
From the HP-50 ASD, miconazole release was slow and incomplete (≈8.6% at 60 min, ≈11.7% at 120 min) while the polymer reached ≈23.3% and ≈42.2%: the polymer left faster than the drug, which the authors call incongruent release. · The HP-50-Na ASD dissolved quickly: ≈89.5% of the drug at 60 min, levelling at ≈91%, with the polymer at a similar or higher fraction (≈106.7% at 60 min). The drug exceeded its amorphous solubility (about 5 µg/mL), a drug-rich phase formed and the medium turned turbid. The PTEA ASD behaved similarly (≈83.7% drug at 60 min, plateau ≈87%). ·· Normalized drug release rates were ≈0.22 (HP-50), ≈2.70 (PTEA) and ≈3.15 mg·min⁻¹·cm⁻² (HP-50-Na); the authors state the HP-50-Na ASD released drug 14 times faster than the HP-50 ASD, and the PTEA ratio is about 12. · The rate units appear to be per ASD mass rather than per drug mass, and polymer values above 100% point to an assay offset. · The authors present this as a "proof-of-concept" with one drug at one loading. ·
04Further observations
- Tg of the salts spans 54.9 °C (PTHAM, DSC onset) to 231.3 °C (HP-Na, DMA peak); DSC and DMA differ by about 46 °C for HP-50. ··
- The 20% DL ASDs have lower Tg than the neat polymers (HP-50 127.1 → 83.4 °C by DSC onset). ·
- HP-50-Na shows its first TGA event at 174.2 °C with 0.47% weight loss.
- Polymer release from the HP-50 ASD (≈42% at 120 min) was below that of neat HP-50 (≈60%). ·
More detail
- Glass transitions. By DSC onset the salts gave 54.9 (PTHAM), 58.1 (PMP), 68.2 (PAMP), 78.1 (PDIP), 84.0 (PTEA), 84.5 (PBTP) and 92.1 °C (PTBA), against 127.1 °C for HP-50; PBTM and HP-Na gave no DSC Tg. By DMA (tan δ peak) PBTM gave 135.7, HP-50 172.8 and HP-Na 231.3 °C. The authors summarize the range as 55 to 231 °C, which mixes the two methods. ··
- ASD glass transitions. The 20% DL ASDs gave 83.4 (HP-50) and 77.2 °C (PTEA) by DSC onset and 142.0, 216.2 (HP-Na) and 116.7 °C by DMA, all below the neat polymers measured by the same method. ···
- Thermal stability of HP-50-Na. TGA events at 174.2 °C (0.47% total weight loss), 267.7 °C (6.8%) and 327.2 °C (26.8%); weight lost below 140 °C was counted as water or solvent. ·
- Water solubility. HP-50-Na dissolves in water, HP-50 does not (no NMR peaks).
- Drug slows the protonated polymer. In the same medium, HP-50 left its 20% miconazole ASD more slowly (≈23.3% at 60 min, ≈42.2% at 120 min) than neat HP-50 compacts (≈28.4% and ≈60.3%). The authors do not comment on this comparison. ·
- Release of the salt polymers exceeds 100%. In both salt ASDs the polymer reached ≈106–112%, which the paper does not discuss. ··
05How the authors connect the findings
More detail
- HPMCP is extensively ionized and soluble at pH 6.8 given its pKa of 4.2, but the pH at the dissolving surface "may differ" from the bulk. For acids dissolving above their pKa, ionization frees protons at the interface; a gradient of about 0.4 pH units was reported for HP-50 films in a phosphate buffer of similar capacity. ··
- Protons leave by diffusion across the boundary layer, by neutralization with hydroxyl ions from the bulk, or on proton carriers. A good carrier must accept a proton at the lower surface pH and give it up at the bulk pH, so its pKa relative to both, and its concentration, set its efficiency. The buffer series "can be largely rationalized" this way: BIS-TRIS (6.5) carries more conjugate base at the surface than phosphate (7.2), while Tris (8.1) and TEA (10.2) are mostly protonated and "cannot act as proton carriers". ·
- Because cation size had no clear effect on rate (buffer cations and salt counterions alike), the authors consider a percolation model "likely not appropriate" and prefer Nguyen and Fogler's view that interfacial polymer solubility, set by surface pH and carrier concentration, controls the rate. Surface pH also sets gel-layer hydration, and the solvent fraction in the gel sets the disentanglement rate. ·
[-] Protonated HP-50. Protons generated at the surface → surface pH low, the more so in a low-capacity or high-pKa buffer → polymer solubility and gel hydration suppressed → slow dissolution (6-fold slower at 3 mM·ΔpH⁻¹). With 20% lipophilic drug the gel layer gets even less water → drug release ≈9% in an hour, polymer ahead of drug. ····
[+] Polymer salt. Already ionized → no protons generated, solubility not suppressed → water uptake higher → more mobile gel layer → chains released quickly, at a rate that does not depend on buffer capacity; the authors say the comparisons "confirm" this and that hydration is "likely a key contributor". In the ASD the extra hydration "likely" offsets the drug's effect on the gel layer → ≈84–90% drug release in an hour. ····
What sets the switch point. Ionization extent. Hydrophobic ionizable polymers need a minimum ionization to dissolve ("perhaps explained"), and the critical ionization of about 83% estimated for HP-50 "may explain" the steep drop between 100 and 80%; partially ionized salts can ionize further but still need some proton removal. ·
Conclusion drawn. "By elucidating that the rate limiting step for HP-50 dissolution is likely polymer solubilization and hydration via ionization", polymers can be designed to dissolve faster; salt formation achieves this and "renders the dissolution process more robust" to buffer capacity. ·
06What it means for formulation
- A polymer salt may give an ASD faster dissolution that is robust to intestinal buffer capacity.
- Polymer salts could allow higher drug loadings without loss of release, which matters for low-potency drugs. ·
- Tests in 50 mM phosphate can overstate how well an HP-50 ASD will release in low-capacity intestinal fluid; a salt removes most of that gap.
More detail
- Using a polymer salt in an ASD "may offer advantages" in dissolution rate and in robustness to the local media conditions of the intestine, whose buffer capacity is variable and much lower than that of 50 mM phosphate. ·
- Because low-potency drugs are hard to formulate as ASDs, the results "highlight the potential advantage of polymer salts to enable higher drug loadings" without compromised release.
- The many pharmaceutically acceptable counterions offer a "relatively unexplored" way to adjust polymer properties and widen the ASD formulation and processing space.
- At higher drug loadings, differences in hydration between salts "may play a role" in when release fails; this is left to a future study.
- In vitro testing of protonated enteric-polymer ASDs in 50 mM phosphate (29 mM·ΔpH⁻¹) can make release look better than in low-capacity intestinal fluid: here HP-50 lost 6-fold in rate at 3 mM·ΔpH⁻¹. A low-capacity medium is a cheap check.
- The counterion barely changed the dissolution rate but changed Tg strongly (about 55 to 92 °C by DSC for the amine salts against 127 °C for HP-50), so the counterion could be chosen for processing or stability rather than for release; the lower Tg of some amine salts could cost physical stability, which was not tested.
- The salts take up 25–42% water at 100% RH and HP-50-Na dissolves in plain water, so the enteric (acid-resistant) function and humidity stability of salt ASDs need checking before use.
07Open questions
- At what drug loading does release from salt ASDs fail, and do hydration differences between salts decide it?
- Surface pH and gel-layer hydration, which carry the explanation, were not measured.
- Only one drug at one loading, in phosphate buffer, was tested; no gastric step or biorelevant medium.
More detail
- How do salt ASDs behave at drug loadings above 20%, and do the differences in hydration between salts decide when release deteriorates?
- The surface pH of dissolving HP-50 in each buffer, the proton flux and the gel-layer water content were not measured; the mechanism rests on rate data, calculated pKa values and a cited surface pH shift. ·
- Why does the sodium salt, with the highest water uptake, not dissolve faster than the amine salts? The authors call this "somewhat surprising". ·
- How do salt ASDs behave after a gastric step (low pH), in biorelevant media, in vivo, and during storage at humidity, given that the salts take up much water? ·
- Was the ASD drug-rich phase amorphous drug, and what was its particle size? The HP-50 ASD medium also exceeded the cited amorphous solubility. ·
- Are the ASDs and salts fully amorphous and chemically stable after preparation? No diffraction data are shown.
08How solid
AI assessment, not a statement made in the paperThe rate effects are large (3-, 6- and 12- to 14-fold), replicated (n = 3) and consistent across figures. But the mechanism is inferred from rates, the SI was not available, the ASD test covers one drug at one loading, and some text overstates the figures. ·····
More detail
- Salt and HP-50 rates differ about 3-fold with tight error bars for HP-50; the HP-50 rate is ≈0.92 mg·min⁻¹·cm⁻² in Figs. 6, 8 and 9, and its release curves in sodium phosphate coincide in Figs. 2 and 5. ····
- The buffer-capacity contrast is large and direct: 6-fold for HP-50 against a small change for HP-50-Na.
- The buffer-species ranking matches buffer pKa across a 25-fold spread in release.
- The ASD result is large: ≈0.22 against ≈2.70–3.15 mg·min⁻¹·cm⁻². ·
- The rate-limiting step is stated as identified in the abstract but "likely" in the discussion; surface pH, proton flux and gel hydration were not measured, and the carrier argument uses calculated pKa values and a cited 0.4-unit surface pH shift. ·
- Hydration as "key contributor" is not borne out among the salts: the sodium salt took up the most water without dissolving faster.
- "Complete" drug release and "the same" normalized rate for drug and polymer overstate the figures (≈84–92% drug; polymer ahead of drug and above 100%). ·
- "The same" rate of HP-50-Na at both buffer capacities is a 12% drop within SD; "no notable difference" among salts is a spread of about 25%; no statistics are reported. ·
- How normalized rates were computed is not stated, and the ASD drug rates appear to be per ASD mass.
- Ionization in Fig. 9 is nominal; the Tg range mixes DSC and DMA; amorphous state of the ASDs is not verified; buffer compositions and buffer-capacity method are not given. ····
- One drug, one drug loading, one buffer system for the ASDs; the SI was not supplied.
09Figure guide
Every figure and table of the paper, what it is there for, and what to check on the original. Key figures are shown with the story.
| Figure | What it does in the paper | Supports | Check (AI note) |
|---|---|---|---|
| Fig. 1 (p.4)key figure | Tests the cation-size idea: five phosphate cations give similar HP-50 release, tetrabutylammonium slightly slower. | F1, K1 | Cation concentrations differ (41–74 mM). |
| Fig. 2 (p.4)key figure | Shows the buffer species matter: BIS-TRIS > phosphate > Tris > TEA. | F1, K1 | Buffer capacities of these buffers not given. |
| Table 1 (p.5)key figure | Defines the nine counterions and their calculated pKa, logP and size. | 0.2 | |
| Fig. 3 (p.5)key figure | Structure of the HP-50 salts.· | 0.2 | A schematic, not data. |
| Fig. 4 (p.5)key figure | Evidence of carboxylate formation in HP-50-Na. | F2 | |
| Table 2 (p.5)key figure | Tg of neat salts and 20% DL ASDs by DSC and DMA. | 0.4 | Range mixes DSC and DMA; DSC stops at 140 °C. |
| Fig. 5 (p.6)key figure | Release profiles: HP-50-Na about 3-fold faster than HP-50. | F3, K2 | |
| Fig. 6 (p.6)key figure | The counterion comparison: all salts ≈2.35–3.09 against ≈0.92 mg·min⁻¹·cm⁻². | F3, K2 | "No notable difference" is not tested statistically. |
| Fig. 7 (p.6)key figure | Water uptake that the authors use to explain faster salt dissolution. | F2, K7 | Not at equilibrium at 96 h; does not rank the salt rates.· |
| Fig. 8 (p.6)key figure | The buffer-capacity test: HP-50 6-fold slower at low capacity, HP-50-Na nearly unchanged. | F4, K3 | HP-50-Na about 12% lower, within SD. |
| Fig. 9 (p.7)key figure | The ionization series with BIS-TRIS. | F5, K4 | Ionization is nominal. |
| Fig. 10 (p.7)key figure | Drug and polymer release from the three 20% DL ASDs. | F6, K5 | Drug ≈84–92%, not complete; polymer above 100%.· |
| Fig. 11 (p.7)key figure | The ASD headline: normalized drug release 14 times faster with HP-50-Na. | F6, K5 | Normalization not stated; likely per ASD mass. |
| Figures S1–S4, S7–S10; Tables S1–S2 (SI, not supplied) | Salt preparation and NMR, hydrated radii, buffer compositions, further buffers, TEA comparison, TGA trace.····· |